Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose vs Oral Iron in Postpartum Iron Deficiency Anemia
NCT07648628Phase 3Completed
- Sponsor
- ESI-PGIMSR
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by ESI-PGIMSR. Started Mar 2024; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07648628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07648628.